| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.29 | 0.03 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |